Insulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065015
  • May 2021
  • Pharmaceuticals
  • 141 Pages
The Insulin Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Sanofi-Aventis, Novo Nordisk, Biocon, Eli Lilly, Wockhardt, Bioton S.A., Julphar(Gulf Pharmaceutical Industries), Pirmal Healthcare, US Vitamins Limited, Abbott
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Insulin market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Insulin market is expected to attain Pre COVID-19 levels by mid-2022.

Insulin Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Insulin market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Insulin Market Competitive and Premeditated Analysis
In the Insulin report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Insulin research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Insulin Market:
The Insulin market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Sanofi-Aventis, Novo Nordisk, Biocon, Eli Lilly, Wockhardt, Bioton S.A., Julphar(Gulf Pharmaceutical Industries), Pirmal Healthcare, US Vitamins Limited, Abbott

The Insulin market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Insulin Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Insulin market:
by Product
Short Acting Insulin
Intermediate Acting Insulin
Long Acting Insulin
Premixed Insulin
Fast Acting Insulin
Indication
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes and Prediabetes

Regional Analysis of the Insulin market:
The Insulin market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Insulin report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Insulin market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Insulin market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Insulin market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Insulin market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Insulin market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Insulin market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Insulin market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Insulin market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Sanofi-Aventis
  • Novo Nordisk
  • Biocon
  • Eli Lilly
  • Wockhardt
  • Bioton S.A.
  • Julphar(Gulf Pharmaceutical Industries)
  • Pirmal Healthcare
  • US Vitamins Limited
  • Abbott
  • Short Acting Insulin
  • Intermediate Acting Insulin
  • Long Acting Insulin
  • Premixed Insulin
  • Fast Acting Insulin
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes and Prediabetes

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Insulin Market Snapshot
          2.1.1. Global Insulin Market By Product,2019
               2.1.1.1.Short Acting Insulin
               2.1.1.2.Intermediate Acting Insulin
               2.1.1.3.Long Acting Insulin
               2.1.1.4.Premixed Insulin
               2.1.1.5.Fast Acting Insulin
          2.1.2. Global Insulin Market By Indication,2019
               2.1.2.1.Product 1 Diabetes
               2.1.2.2.Product 2 Diabetes
               2.1.2.3.Gestational Diabetes and Prediabetes
          2.1.3. Global Insulin Market By End-use,2019
          2.1.4. Global Insulin Market By Geography,2019

3. Global Insulin Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Insulin Market Size (US$), By Product, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product, 2020
     4.2. Global Insulin Market Size (US$), By Product, 2018 – 2028

5. Global Insulin Market Size (US$), By Indication, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Indication, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Indication, 2020
     5.2. Global Insulin Market Size (US$), By Indication, 2018 – 2028

6. Global Insulin Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Insulin Market Size (US$), By End-use, 2018 – 2028

7. Global Insulin Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Insulin Market Analysis, 2018 – 2028 
          7.2.1. North America Insulin Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Insulin Market Size (US$), By Product, 2018 – 2028
          7.2.3. North America Insulin Market Size (US$), By Indication, 2018 – 2028
          7.2.4. North America Insulin Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Insulin Market Analysis, 2018 – 2028 
          7.3.1.  Europe Insulin Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Insulin Market Size (US$), By Product, 2018 – 2028
          7.3.3. Europe Insulin Market Size (US$), By Indication, 2018 – 2028
          7.3.4. Europe Insulin Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Insulin Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Insulin Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Insulin Market Size (US$), By Product, 2018 – 2028
          7.4.3. Asia Pacific Insulin Market Size (US$), By Indication, 2018 – 2028
          7.4.4. Asia Pacific Insulin Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Insulin Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Insulin Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Insulin Market Size (US$), By Product, 2018 – 2028
          7.5.3. Latin America Insulin Market Size (US$), By Indication, 2018 – 2028
          7.5.4. Latin America Insulin Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Insulin Market Analysis, 2018 – 2028 
          7.6.1.  MEA Insulin Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Insulin Market Size (US$), By Product, 2018 – 2028
          7.6.3. MEA Insulin Market Size (US$), By Indication, 2018 – 2028
          7.6.4. MEA Insulin Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Insulin Providers
        8.4.1 Sanofi-Aventis
                8.4.1.1 Business Description
                8.4.1.2 Sanofi-Aventis Geographic Operations
                8.4.1.3 Sanofi-Aventis Financial Information
                8.4.1.4 Sanofi-Aventis Product Positions/Portfolio
                8.4.1.5 Sanofi-Aventis Key Developments
        8.4.2 Novo Nordisk
                8.4.2.1 Business Description
                8.4.2.2 Novo Nordisk Geographic Operations
                8.4.2.3 Novo Nordisk Financial Information
                8.4.2.4 Novo Nordisk Product Positions/Portfolio
                8.4.2.5 Novo Nordisk Key Developments
        8.4.3 Biocon
                8.4.3.1 Business Description
                8.4.3.2 Biocon Geographic Operations
                8.4.3.3 Biocon Financial Information
                8.4.3.4 Biocon Product Positions/Portfolio
                8.4.3.5 Biocon Key Developments
        8.4.4 Eli Lilly
                8.4.4.1 Business Description
                8.4.4.2 Eli Lilly Geographic Operations
                8.4.4.3 Eli Lilly Financial Information
                8.4.4.4 Eli Lilly Product Positions/Portfolio
                8.4.4.5 Eli Lilly Key Developments
        8.4.5 Wockhardt
                8.4.5.1 Business Description
                8.4.5.2 Wockhardt Geographic Operations
                8.4.5.3 Wockhardt Financial Information
                8.4.5.4 Wockhardt Product Positions/Portfolio
                8.4.5.5 Wockhardt Key Developments
        8.4.6 Bioton S.A.
                8.4.6.1 Business Description
                8.4.6.2 Bioton S.A. Geographic Operations
                8.4.6.3 Bioton S.A. Financial Information
                8.4.6.4 Bioton S.A. Product Positions/Portfolio
                8.4.6.5 Bioton S.A. Key Developments
        8.4.7 Julphar(Gulf Pharmaceutical Industries)
                8.4.7.1 Business Description
                8.4.7.2 Julphar(Gulf Pharmaceutical Industries) Geographic Operations
                8.4.7.3 Julphar(Gulf Pharmaceutical Industries) Financial Information
                8.4.7.4 Julphar(Gulf Pharmaceutical Industries) Product Positions/Portfolio
                8.4.7.5 Julphar(Gulf Pharmaceutical Industries) Key Developments
        8.4.8 Pirmal Healthcare
                8.4.8.1 Business Description
                8.4.8.2 Pirmal Healthcare Geographic Operations
                8.4.8.3 Pirmal Healthcare Financial Information
                8.4.8.4 Pirmal Healthcare Product Positions/Portfolio
                8.4.8.5 Pirmal Healthcare Key Developments
        8.4.9 US Vitamins Limited
                8.4.9.1 Business Description
                8.4.9.2 US Vitamins Limited Geographic Operations
                8.4.9.3 US Vitamins Limited Financial Information
                8.4.9.4 US Vitamins Limited Product Positions/Portfolio
                8.4.9.5 US Vitamins Limited Key Developments
        8.4.10 Abbott
                8.4.10.1 Business Description
                8.4.10.2 Abbott Geographic Operations
                8.4.10.3 Abbott Financial Information
                8.4.10.4 Abbott Product Positions/Portfolio
                8.4.10.5 Abbott Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Insulin Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Insulin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Insulin Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Insulin Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Insulin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Insulin Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Insulin Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Insulin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Insulin Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Insulin Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Insulin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Insulin Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Insulin Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Insulin Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Insulin Market Revenue, By Indication, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Insulin Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Insulin: Market Segmentation 
FIG. 2 Global Insulin Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Insulin Market, By Product, 2019 (US$ Mn) 
FIG. 5 Global Insulin Market, By Indication, 2019 (US$ Mn) 
FIG. 6 Global Insulin Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Insulin Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Insulin Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Insulin Providers, 2019
FIG. 11 Global Insulin Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 12 Global Insulin Market Revenue Contribution, By Indication, 2019 & 2028 (Value %) 
FIG. 13 Global Insulin Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Insulin Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Insulin Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Insulin Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Insulin Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Insulin Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Insulin market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Insulin Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Insulin Market Value, By Segment1, 2018 – 2028
TABLE  North America Insulin Market Value, By Segment2, 2018 – 2028
TABLE  North America Insulin Market Value, By Country, 2018 – 2028
TABLE  Europe Insulin Market Value, By Segment1, 2018 – 2028
TABLE  Europe Insulin Market Value, By Segment2, 2018 – 2028
TABLE  Europe Insulin Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Insulin Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Insulin Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Insulin Market Value, By Country, 2018 – 2028
TABLE  Latin America Insulin Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Insulin Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Insulin Market Value, By Country, 2018 – 2028
TABLE  MEA Insulin Market Value, By Segment1, 2018 – 2028
TABLE  MEA Insulin Market Value, By Segment2, 2018 – 2028
TABLE  MEA Insulin Market Value, By Country, 2018 – 2028
TABLE  Sanofi-Aventis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novo Nordisk: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocon: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Wockhardt: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bioton S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Julphar(Gulf Pharmaceutical Industries): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pirmal Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  US Vitamins Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Insulin Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Insulin Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Insulin Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Insulin Market, By Geography, 2019 (US$ Mn)
FIG.  Global Insulin Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Insulin Providers, 2016
FIG.  Global Insulin Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Intermediate Acting Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Long Acting Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Premixed Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Fast Acting Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Insulin Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Type 2 Diabetes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Gestational Diabetes and Prediabetes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Insulin Market Value, 2018 – 2028, (US$ Mn)